Influence of ghrelin and adipocytokines on bone mineral density in adolescent female athletes with amenorrhea and eumenorrheic athletes

Medicine and Sport Science

Volumn 55, Issue , 2010, Pages 103-113

  Russell, Melissa ^a   Misra, Madhusmita ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GHRELIN; GONADOTROPIN; PEPTIDE YY;

ADOLESCENT; AMENORRHEA; ARTICLE; BLOOD; BODY FAT DISTRIBUTION; BODY MASS; BONE DENSITY; BONE DEVELOPMENT; ENERGY METABOLISM; FEMALE; HUMAN; MENSTRUAL CYCLE; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; SPORT;

ADIPOKINES; ADOLESCENT; AMENORRHEA; BODY FAT DISTRIBUTION; BODY MASS INDEX; BONE DENSITY; ENERGY METABOLISM; FEMALE; GHRELIN; GONADOTROPINS; HUMANS; MENSTRUAL CYCLE; OSTEOGENESIS; PEPTIDE YY; SPORTS;

EID: 78249281377     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000321975     Document Type: Article

References (62)

1. Bachrach L: Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 2001;12:22-28.
2. Christo K, Cord J, Mendes N, et al: Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study. Clin Endocrinol (Oxf) 2008;69:628-633.
3. Russell M, Stark J, Nayak S, et al: Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 2009;45: 104-109.
4. Cobb K, Bachrach L, Greendale G, et al: Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003;35:711-719.
5. Myburgh H, Hutchins J, Fataar A, Hough S, Noakes T: Low bone mineral density is an etiologic factor for stress fractures in athletes. Ann Intern Med 1990;113:754-759.
6. Myburgh K, Bachrach L, Lewis B, Kent K, Marcus R: Low bone mineral density at axial and appendicular sites in amenorrheic athletes. Med Sci Sports Exerc 1993;25:1197-1202.
7. Pettersson U, Stalnacke B, Ahlenius G, Henriksson- Larsen K, Lorentzon R: Low bone mass density at multiple skeletal sites, including the appendicular skeleton in amenorrheic runners. Calcif Tissue Int 1999;64:117-125.
8. Loud KJ, Gordon CM, Micheli LJ, Field AE: Correlates of stress fractures among preadolescent and adolescent girls. Pediatrics 2005;115:e399-e406.
9. Christo K, Prabhakaran R, Lamparello B, et al: Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics 2008;121:1127-1136.
10. Robinson TL, Snow-Harter C, Taaffe DR, et al: Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J Bone Miner Res 1995;10:26-35.
11. Snow C, Rosen C, Robinson T: Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass. Med Sci Sports Exerc 2000;32:1902-1907.
12. Misra M, Prabhakaran R, Miller KK, et al: Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008; 93:1231-1237.
13. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC: Growth hormone and bone. Endocr Rev 1998;19:55-79.
14. Rauch F: Bone accrual in children: adding substance to surfaces. Pediatrics 2007;119(suppl 2): S137-S140.
15. Nichols JF, Rauh MJ, Lawson MJ, Ji M, Barkai HS: Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006;160:137-142.
16. Drinkwater BL, Bruemner B, Chesnut CH 3rd: Menstrual history as a determinant of current bone density in young athletes. JAMA 1990;263:545-548.
17. Jones KP, Ravnikar VA, Tulchinsky D, Schiff I: Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause. Obstet Gynecol 1985;66:5-8.
18. Rencken ML, Chesnut CH 3rd, Drinkwater BL: Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996;276:238-240.
19. Wolman RL, Clark P, McNally E, Harries M, Reeve J: Menstrual state and exercise as determinants of spinal trabecular bone density in female athletes. BMJ 1990;301:516-518.
20. Loucks AB, Verdun M, Heath EM: Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998;84:37-46.
21. Misra M, Prabhakaran R, Miller KK, et al: Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 2006;59:598-603. (Pubitemid 43740064)
22. Welt CK, Chan JL, Bullen J, et al: Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
23. Ducy P, Amling M, Takeda S, et al: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
24. Hamrick MW, Pennington C, Newton D, Xie D, Isales C: Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004;34:376-383.
25. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG: Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000;92:73-78.
26. Lu M, Tang Q, Olefsky JM, Mellon PL, Webster NJ: Adiponectin activates adenosine monophosphateactivated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Mol Endocrinol 2008;22:760-771.
27. Luo XH, Guo LJ, Xie H, et al: Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006;21:1648-1656.
28. Luo XH, Guo LJ, Yuan LQ, et al: Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005;309:99-109.
29. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, et al: Regulation of pituitary cell function by adiponectin. Endocrinology 2007;148:401-410.
30. Fukushima N, Hanada R, Teranishi H, et al: Ghrelin directly regulates bone formation. J Bone Miner Res 2005;20:790-798.
31. Kluge M, Schussler P, Uhr M, Yassouridis A, Steiger A: Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007;92: 3202-3205.
32. Baldock PA, Sainsbury A, Couzens M, et al: Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002;109:915-921.
33. Fernandez-Fernandez R, Aguilar E, Tena-Sempere M, Pinilla L: Effects of polypeptide YY(3-36) upon luteinizing hormone-releasing hormone and gonadotropin secretion in prepubertal rats: in vivo and in vitro studies. Endocrinology 2005;146:1403-1410. (Pubitemid 40289329)
34. Misra M, Miller KK, Tsai P, et al: Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006;91:1027-1033. (Pubitemid 43357776)
35. Considine RV, Sinha MK, Heiman ML, et al: Serum immunoreactive-leptin concentrations in normalweight and obese humans. N Engl J Med 1996;334: 292-295.
36. Kennedy A, Gettys TW, Watson P, et al: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997;82:1293-1300.
37. Saad MF, Riad-Gabriel MG, Khan A, et al: Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab 1998;83:453-459.
38. Cambuli VM, Musiu MC, Incani M, et al: Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 2008;93:3051-3057.
39. Yang WS, Lee WJ, Funahashi T, et al: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819.
40. Misra M, Miller KK, Kuo K, et al: Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005;289:E373-E381. (Pubitemid 41192692)
41. Farooqi IS: Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med 2002;20:139-144.
42. Misra M, Miller KK, Cord J, et al: Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007;92:2046-2052.
43. Pannacciulli N, Bunt JC, Ortega E, et al: Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab 2006;91:1600-1603.
44. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME: Playing with bone and fat. J Cell Biochem 2006;98:251-266.
45. Pei L, Tontonoz P: Fats loss is bones gain. J Clin Invest 2004;113:805-806.
46. Jurimae J, Rembel K, Jurimae T, Rehand M: Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005;37: 297-302.
47. Lenchik L, Register TC, Hsu FC, et al: Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003;33:646-651.
48. Nakazato M, Murakami N, Date Y, et al: A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
49. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000;407:908-913.
50. De Souza MJ, Leidy HJ, O'Donnell E, Lasley B, Williams NI: Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004;89:3536-3542.
51. Jurimae J, Jurimae T, Purge P: Plasma ghrelin is altered after maximal exercise in elite male rowers. Exp Biol Med (Maywood) 2007;232:904-909. (Pubitemid 47026796)
52. Hotta M, Ohwada R, Katakami H, et al: Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 2004;89:5707-5712.
53. Misra M, Miller KK, Kuo K, et al: Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005;289:E347-E356. (Pubitemid 41076638)
54. Vulliemoz NR, Xiao E, Xia-Zhang L, et al: Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004;89:5718-5723.
55. Kamegai J, Tamura H, Shimizu T, et al: Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001;50: 2438-2443. (Pubitemid 33642759)
56. Arvat E, Maccario M, Di Vito L, et al: Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169-1174.
57. Takaya K, Ariyasu H, Kanamoto N, et al: Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000;85:4908-4911.
58. Misra M, Miller KK, Stewart V, et al: Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005;90:5082-5087. (Pubitemid 41262258)
59. Huda MS, Wilding JP, Pinkney JH: Gut peptides and the regulation of appetite. Obes Rev 2006;7:163-182.
60. Ballantyne GH: Peptide YY(1-36) and peptide YY(3-36). II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006;16:795-803.
61. Keire DA, Mannon P, Kobayashi M, et al: Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 2000; 279:G126-G131.
62. Batterham RL, Cohen MA, Ellis SM, et al: Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349:941-948.